OR WAIT 15 SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
K. John Morrow, Jr., PhD, is president of Newport Biotechnology Consultants, 625 Washington Avenue, Newport, KY 41071, email@example.com.
The authors review the angiopoietin pathway as an alternative for safer and more efficacious anti-angiogenic therapeutics.
Innovative products and a range of indications drive the therapeutic antibody market.
Therapeutics targeting epigenetic mechanisms of disease will change the pharmaceutical marketplace.
Two films portray, in surprising detail, the hard work and determination of the biopharmaceutical industry.